Tumor Suppression in Asymptomatic Postmenopausal Endometrial Polyps.

Area of Science:

• Gynecologic pathology
• Oncology
• Molecular diagnostics

Background:

• Endometrial polyps are common in postmenopausal women.
• Assessing malignization potential is crucial for clinical management.
• Tumor suppressor genes like PTEN are critical in cancer development.

Purpose of the Study:

• To evaluate tumor suppression via PTEN expression in endometrial polyps.
• To determine if PTEN levels can predict malignization potential in asymptomatic postmenopausal women.

Main Methods:

• Immunohistochemical analysis of PTEN in endometrial polyps and carcinomas.
• Quantitative scoring of PTEN staining intensity in epithelial and stromal compartments.
• Comparison of PTEN levels between benign polyps, carcinomas, atrophic endometria, and premenopausal polyps.

Main Results:

• Postmenopausal benign polyps exhibited significantly higher PTEN H-scores than atrophic endometria and premenopausal polyps.
• A significant difference in epithelial PTEN levels was observed between postmenopausal polyps and endometrial carcinoma.
• Elevated PTEN expression in benign postmenopausal polyps suggests a protective role.

Conclusions:

• Asymptomatic benign postmenopausal polyps demonstrate high tumor suppression.
• PTEN expression levels in endometrial polyps may serve as an indicator of low malignization potential.
• Findings support the role of PTEN in distinguishing benign from malignant endometrial lesions.